Skip to main content

Polar Capital Healthcare Opportunities Fund

Polar Capital Healthcare Opportunities Fund is an equity fund managed by Polar Capital in the Sektor – Helse category.

About this fund

Polar Capital Healthcare Opportunities Fund sits in the Sektor – Helse peer group, where Polar Capital is the manager.

The fund: 19 years of track record, running since 2007 (share classes may be younger).

It is run by a team of 4.

The reference index is MSCI AC World Daily Total Return Net Health Care Index.

Manager
Polar Capital
Category
Sektor – Helse
Region
Global
SFDR
Article 8
ISIN
IE00B3K93X10
Inception
2007-11-30
Benchmark
MSCI AC World Daily Total Return Net Health Care Index
AUM
2.3 bn USD
Returns
1Y -2.9% · 3Y 9.7% · 5Y 8.4%

Portfolio managers

Actively managedEquityGlobal
YTD Return · NOK
–
Calculated NOK return from USD · USD Class I Dist (NOK Calculated)
Last NAV 98,17 USD · 13 Nov 2026
Returns by period · NOK · net
ann. 3Y+
−2,9 %
1y
+9,7 %
3y, annualised
+8,4 %
5y, annualised
+12,1 %
10y, annualised
Fund size
2,3 mrd. USD
Total fund AUM
Ongoing charge
1,10 %
Annual · class I USD Utb.
Performance fee
10%
of the excess return
SFDR
Article 8
Sustainability
Launched
Nov 2007
ISIN IE00BKSBD728
BenchmarkMSCI ACWI Health Care · Net
About the fund
The fund

Polar Capital Healthcare Opportunities Fund is an actively managed global healthcare equity fund with history back to 2007, the year Polar Capital set up its healthcare team. The benchmark is the MSCI AC World Health Care index. The management company, Polar Capital, is a specialist asset manager founded in 2001 and headquartered in London. The parent company is listed on AIM with a dispersed shareholder base, and investment management is organised in relatively autonomous investment teams.

Investment philosophy

Polar Capital describes high-conviction active positions, and the portfolio bears this out: its active share against the benchmark is higher than that of comparable funds. The healthcare team manages both broad healthcare funds and a specialised biotechnology fund. Several of the same companies recur as top holdings across the funds, which points to shared convictions.

The managers

The fund is led by Gareth Powell, founder and head of the healthcare team. He joined Polar Capital in 2007 to build the team and has a background in biochemistry and in healthcare and biotechnology management at Framlington. David Pinniger, Deane Donnigan and James Douglas are listed alongside him, and responsibility appears to be shared within a specialist team. Pinniger and Donnigan joined Polar Capital in 2013 and Douglas in 2015. Powell and Pinniger are based in London. Their backgrounds range from pharmacy and medicinal chemistry to research and equity sales in healthcare. They also manage funds such as the Polar Capital Biotechnology Fund, Global Healthcare Select Fund and Healthcare Discovery Fund.

The portfolio

The United States is the largest country in the portfolio. Companies that have remained among the top holdings include large pharmaceutical companies such as Novartis, Johnson & Johnson and Eli Lilly, alongside smaller biotechnology companies such as Xenon Pharmaceuticals and Enliven Therapeutics. The bulk of the portfolio is in large and mid-sized companies, with a smaller share in small ones.

FundTelligence description · 18/10/2026

Portfolio managers

DA
Fund Manager
DE
Fund Manager
GA
Head of Healthcare
JA
Fund Manager

Fund data is taken from the managers’ own reports, otherwise computed from NAV history and, as a last resort, taken from distributor listings. Not official figures; verify with the fund provider before investing.

About our data